Business Description
Fisher & Paykel Healthcare Corp Ltd
ISIN : NZFAPE0001S2
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 0.69 | |||||
Interest Coverage | 19.08 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 22.72 | |||||
Beneish M-Score | -2.17 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.5 | |||||
3-Year EBITDA Growth Rate | -0.3 | |||||
3-Year EPS without NRI Growth Rate | -4.6 | |||||
3-Year FCF Growth Rate | -43.9 | |||||
3-Year Book Growth Rate | 21.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 11.2 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.26 | |||||
9-Day RSI | 57.16 | |||||
14-Day RSI | 57.11 | |||||
6-1 Month Momentum % | 25.66 | |||||
12-1 Month Momentum % | -4.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.54 | |||||
Quick Ratio | 1.29 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 200.31 | |||||
Days Sales Outstanding | 43.82 | |||||
Days Payable | 82.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.64 | |||||
Dividend Payout Ratio | 0.89 | |||||
3-Year Dividend Growth Rate | 19.9 | |||||
Forward Dividend Yield % | 1.64 | |||||
5-Year Yield-on-Cost % | 3.77 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 0.7 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.06 | |||||
Operating Margin % | 15.84 | |||||
Net Margin % | 15.31 | |||||
FCF Margin % | 2.13 | |||||
ROE % | 15.75 | |||||
ROA % | 11.74 | |||||
ROIC % | 10.37 | |||||
ROC (Joel Greenblatt) % | 23.59 | |||||
ROCE % | 19.25 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 58.89 | |||||
Forward PE Ratio | 45.66 | |||||
PE Ratio without NRI | 58.89 | |||||
Shiller PE Ratio | 56.33 | |||||
Price-to-Owner-Earnings | 73.04 | |||||
PEG Ratio | 4.99 | |||||
PS Ratio | 9.01 | |||||
PB Ratio | 8.78 | |||||
Price-to-Tangible-Book | 9.35 | |||||
Price-to-Free-Cash-Flow | 498.87 | |||||
Price-to-Operating-Cash-Flow | 39.29 | |||||
EV-to-EBIT | 42.8 | |||||
EV-to-Forward-EBIT | 30.65 | |||||
EV-to-EBITDA | 33.46 | |||||
EV-to-Forward-EBITDA | 24.19 | |||||
EV-to-Revenue | 9.22 | |||||
EV-to-Forward-Revenue | 7.81 | |||||
EV-to-FCF | 507.97 | |||||
Price-to-Projected-FCF | 4.01 | |||||
Price-to-DCF (Earnings Based) | 2.23 | |||||
Price-to-DCF (FCF Based) | 27.69 | |||||
Price-to-Median-PS-Value | 1.24 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.29 | |||||
Price-to-Graham-Number | 4.98 | |||||
Price-to-Net-Current-Asset-Value | 160 | |||||
Earnings Yield (Greenblatt) % | 2.34 | |||||
FCF Yield % | 0.2 | |||||
Forward Rate of Return (Yacktman) % | 12.9 |